28.06.2018 • NewsElaine BurridgeOxea

Oxea Hikes German NPG Capacity

Oxea Hikes German NPG Capacity (c) Oxea
Oxea Hikes German NPG Capacity (c) Oxea

German oxo-chemicals company Oxea has announced plans to increase capacity for neopentyl glycol (NPG) at its site in Oberhausen. Basic engineering on the debottlenecking project has started and the additional output is expected to be available by early 2020. Capacity figures were not disclosed.

“We are convinced that the NPG market is growing.  But while capacities for NPG are being added in Asia, European capacities are not expanding in line with demand growth,” said Matthias Freitag, Oxea’s global commercial business director polyols and plasticizers. He added that based on customer requirements, Oxea will produce NPG molten, 90% slurry and flakes, for small to large industrial customers. NPG is used in the synthesis of polyesters, coatings, lubricants and plasticizers.

Separately, the Monheim-based group confirmed that its new propanol production plant at Bay City, Texas, USA, is now mechanically complete. The 100,000 t/y Propanol 2 facility is scheduled to produce commercial volumes in the third quarter.

Naoko Roth, Oxea’s marketing director US oxo intermediates, said that with the additional capacity, Oxea can expand further into existing and future growth markets.

CHEManager Spotlight

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics
Creating Interfaces

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics

CHEManager Spotlight is an exclusive event tailored for practitioners and decision-makers in the chemical industry. This part of our event series delves into the latest trends and innovations in logistics to streamline your operations and drive efficiency.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.